These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17136977)

  • 1. Bridging the gap: using triangulation methodology to estimate minimal clinically important differences (MCIDs).
    Leidy NK; Wyrwich KW
    COPD; 2005 Mar; 2(1):157-65. PubMed ID: 17136977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The breathlessness, cough, and sputum scale: the development of empirically based guidelines for interpretation.
    Leidy NK; Rennard SI; Schmier J; Jones MK; Goldman M
    Chest; 2003 Dec; 124(6):2182-91. PubMed ID: 14665499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies.
    Ferguson GT; Karpel J; Bennett N; Clerisme-Beaty E; Grönke L; Voß F; Buhl R
    NPJ Prim Care Respir Med; 2017 Feb; 27(1):7. PubMed ID: 28154373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease.
    Tabberer M; Brooks J; Wilcox T
    Health Qual Life Outcomes; 2015 Oct; 13():177. PubMed ID: 26520062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating symptoms in chronic obstructive pulmonary disease: validation of the Breathlessness, Cough and Sputum Scale.
    Leidy NK; Schmier JK; Jones MK; Lloyd J; Rocchiccioli K
    Respir Med; 2003 Jan; 97 Suppl A():S59-70. PubMed ID: 12564612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease.
    Donohue JF; Jones PW; Bartels C; Marvel J; D'Andrea P; Banerji D; Morris DG; Patalano F; Fogel R
    Pulm Pharmacol Ther; 2018 Apr; 49():11-19. PubMed ID: 29277690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO
    Ferguson GT; Karpel JP; Clerisme-Beaty E; Grönke L; Voß F; Buhl R
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2701-2710. PubMed ID: 27843306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease.
    Schlecht NF; Schwartzman K; Bourbeau J
    Chron Respir Dis; 2005; 2(4):183-91. PubMed ID: 16541601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease.
    Checkley W; Foreman MG; Bhatt SP; Dransfield MT; Han M; Hanania NA; Hansel NN; Regan EA; Wise RA;
    Respir Med; 2016 Feb; 111():30-8. PubMed ID: 26712569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype of Spirometric Impairment in an Aging Population.
    Vaz Fragoso CA; McAvay G; Van Ness PH; Casaburi R; Jensen RL; MacIntyre N; Yaggi HK; Gill TM; Concato J
    Am J Respir Crit Care Med; 2016 Apr; 193(7):727-35. PubMed ID: 26540012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue medication use as a patient-reported outcome in COPD: a systematic review and regression analysis.
    Punekar YS; Sharma S; Pahwa A; Takyar J; Naya I; Jones PW
    Respir Res; 2017 May; 18(1):86. PubMed ID: 28482883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal Clinically Important Differences and Feasibility of Dyspnea-12 and the Multidimensional Dyspnea Profile in Cardiorespiratory Disease.
    Ekström MP; Bornefalk H; Sköld CM; Janson C; Blomberg A; Bornefalk-Hermansson A; Igelström H; Sandberg J; Sundh J
    J Pain Symptom Manage; 2020 Nov; 60(5):968-975.e1. PubMed ID: 32512047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of indacaterol and tiotropium in COPD patients according to dyspnoea severity.
    Mahler DA; Buhl R; Lawrence D; McBryan D
    Pulm Pharmacol Ther; 2013 Jun; 26(3):348-55. PubMed ID: 23434446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of indacaterol 75 μg once-daily on dyspnea and health status: results of two double-blind, placebo-controlled 12-week studies.
    Gotfried MH; Kerwin EM; Lawrence D; Lassen C; Kramer B
    COPD; 2012 Dec; 9(6):629-36. PubMed ID: 23020650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor analysis of laboratory and clinical measurements of dyspnea in patients with chronic obstructive pulmonary disease.
    Nguyen HQ; Altinger J; Carrieri-Kohlman V; Gormley JM; Stulbarg MS
    J Pain Symptom Manage; 2003 Feb; 25(2):118-27. PubMed ID: 12590027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically relevant differences in COPD health status: systematic review and triangulation.
    Alma H; de Jong C; Tsiligianni I; Sanderman R; Kocks J; van der Molen T
    Eur Respir J; 2018 Sep; 52(3):. PubMed ID: 30139774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study.
    LaForce C; Feldman G; Spangenthal S; Eckert JH; Henley M; Patalano F; D'Andrea P
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1233-43. PubMed ID: 27354782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis.
    Ismaila AS; Huisman EL; Punekar YS; Karabis A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2495-517. PubMed ID: 26604738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of aclidinium bromide in patients with COPD: A phase 3 randomized clinical trial in a Korean population.
    Lee SH; Lee J; Yoo KH; Uh ST; Park MJ; Lee SY; Kim JY; Kim DK; Kim SJ; Lee KH; Yoo CG
    Respirology; 2015 Nov; 20(8):1222-8. PubMed ID: 26370136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.